Institute for Cannabinoid Research
An independent, interdisciplinary initiative dedicated to advancing scientific research on the endocannabinoid system and cannabinoid-based therapies.
Institute for Cannabinoid Research(ICR)
Advancing global cannabinoid science through research, clinical innovation, and education.
Institute for Cannabinoid Research (ICR) is an independent, interdisciplinary organization dedicated to advancing scientific understanding of cannabinoids and the endocannabinoid system. Through rigorous research, clinical expertise, and international collaboration, we translate scientific insights into meaningful impact for patients, professionals, and society.
Our Mission ICR’s mission is to expand global knowledge of cannabinoids and the endocannabinoid system by conducting high‑quality research, providing clinical guidance, and fostering international scientific exchange. We serve as a trusted source of evidence‑based information for clinicians, researchers, policymakers, and the public.
Clinical Expertise Our clinic provides complementary cannabinoid‑based therapy for individuals with chronic medical conditions, including cancer, persistent pain, rheumatic disorders, and neurological diseases. We also support individuals without a formal diagnosis who seek preventive or wellness‑oriented cannabinoid guidance for stress, sleep, pain, or seasonal health issues.
Our approach integrates conventional medicine with scientifically grounded cannabinoid interventions.
Research Focus
The institute conducts and supports research in the following areas:
– Therapeutic applications of cannabinoids in chronic diseases
– Medicinal and pharmacological mechanisms of the endocannabinoid system
– Behavioral and psychological effects of cannabis
– Drug interactions and safety profiles and genetic profiling of Cannabinoid receptor and enzyme status
– Clinical and preclinical studies on cannabinoids
– Personalized responses based on age, sex, and biological factors
Clinical Approach & Advisory
The institute provides supplementary cannabinoid-based treatment approaches for patients with chronic conditions, including cancer, neurological disorders, and persistent pain. These approaches are designed to complement conventional medical treatments.In addition, the institute offers expert second opinions based on the latest scientific evidence, providing alternative perspectives beyond standard treatment guidelines.
Oncological diseases
Endocannabinoid System in oncological diseases
The institute’s research spans a wide range of scientific and clinical domains:
– Cannabinoid-based therapies in chronic diseases
– Endocannabinoid system modulation
– Neurodegenerative and psychiatric disorders
– Pain, stress, and anxiety-related conditions
– Epigenetics and immunological mechanisms
